dbSNP rs1150: VAMP2:c.*1590T>C (chr17-8159265-A-G) – ACMG Classification: Benign (-10 pts)

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_014232.3(VAMP2):c.*1590T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.669 in 151,260 control chromosomes in the GnomAD database, including 34,117 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.67 ( 34105 hom., cov: 27)

Exomes 𝑓: 0.79 ( 12 hom. )

Consequence

VAMP2
NM_014232.3 3_prime_UTR

Scores

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.06

Publications

24 publications found

Variant links:

Genes affected

VAMP2 (HGNC:12643): (vesicle associated membrane protein 2) The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. This gene is thought to participate in neurotransmitter release at a step between docking and fusion. The protein forms a stable complex with syntaxin, synaptosomal-associated protein, 25 kD, and synaptotagmin. It also forms a distinct complex with synaptophysin. It is a likely candidate gene for familial infantile myasthenia (FIMG) because of its map location and because it encodes a synaptic vesicle protein of the type that has been implicated in the pathogenesis of FIMG. [provided by RefSeq, Jul 2008]

VAMP2 Gene-Disease associations (from GenCC):

neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements
Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

VAMP2 links:

ENSG00000263620 (HGNC:):

ENSG00000263620 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.43).

BA1

GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
VAMP2	NM_014232.3 link	c.*1590T>C		3_prime_UTR_variant	Exon 5 of 5	ENST00000316509.11	NP_055047.2	P63027
VAMP2	NM_001330125.1 link	c.*1590T>C		3_prime_UTR_variant	Exon 5 of 5		NP_001317054.1	F8WCA0

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
VAMP2	ENST00000316509.11 link	c.*1590T>C		3_prime_UTR_variant	Exon 5 of 5	1	NM_014232.3	ENSP00000314214.6		P63027
ENSG00000263620	ENST00000498285.1 link	c.334+2208T>C		intron_variant	Intron 4 of 4	4		ENSP00000464383.1		L7N2F9

Frequencies

GnomAD3 genomes

AF:

0.669

AC:

101124

AN:

151100

Hom.:

34080

Cov.:

show subpopulations

Gnomad AFR

AF:

0.645

Gnomad AMI

AF:

0.629

Gnomad AMR

AF:

0.698

Gnomad ASJ

AF:

0.491

Gnomad EAS

AF:

0.496

Gnomad SAS

AF:

0.729

Gnomad FIN

AF:

0.780

Gnomad MID

AF:

0.592

Gnomad NFE

AF:

0.680

Gnomad OTH

AF:

0.651

GnomAD4 exome

AF:

0.786

AC:

AN:

Hom.:

Cov.:

AF XY:

0.778

AC XY:

AN XY:

show subpopulations

African (AFR)

AC:

AN:

American (AMR)

AC:

AN:

Ashkenazi Jewish (ASJ)

AC:

AN:

East Asian (EAS)

AC:

AN:

South Asian (SAS)

AC:

AN:

European-Finnish (FIN)

AF:

0.765

AC:

AN:

Middle Eastern (MID)

AC:

AN:

European-Non Finnish (NFE)

AF:

0.875

AC:

AN:

Other (OTH)

AC:

AN:

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.525

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

GnomAD4 genome

AF:

0.669

AC:

101194

AN:

151218

Hom.:

34105

Cov.:

AF XY:

0.675

AC XY:

49800

AN XY:

73820

show subpopulations

African (AFR)

AF:

0.645

AC:

26515

AN:

41114

American (AMR)

AF:

0.698

AC:

10594

AN:

15186

Ashkenazi Jewish (ASJ)

AF:

0.491

AC:

1703

AN:

3470

East Asian (EAS)

AF:

0.497

AC:

2547

AN:

5128

South Asian (SAS)

AF:

0.729

AC:

3493

AN:

4792

European-Finnish (FIN)

AF:

0.780

AC:

8153

AN:

10450

Middle Eastern (MID)

AF:

0.589

AC:

172

AN:

292

European-Non Finnish (NFE)

AF:

0.680

AC:

46092

AN:

67792

Other (OTH)

AF:

0.649

AC:

1358

AN:

2092

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.509

Heterozygous variant carriers

1637

3274

4912

6549

8186

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Genome Hom

Variant carriers

810

1620

2430

3240

4050

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.666

Hom.:

48475

Bravo

AF:

0.658

Asia WGS

AF:

0.626

AC:

2177

AN:

3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.43

CADD

Benign

(source)

DANN

Benign

0.83

PhyloP100

1.1

RBP_binding_hub_radar

0.0

RBP_regulation_power_radar

1.1

Mutation Taster

=100/0

polymorphism (auto)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

ClinVar

Computational scores

Splicing

Publications

Other links and lift over